Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors.
Data Sources
Data sources we collected to analyse this study.
Full Text
PDF
Crossref
PubMed
Classification
Summary
Quality Score
Content
Study Identifiers & Links
Access this study on other platforms
Data Sources
Data sources we collected to analyse this study.
Full Text
PDF
Crossref
PubMed
Classification
Summary
Quality Score
Content
Study Identifiers & Links
Access this study on other platforms
Publication
Journal
Journal of pharmaceutical sciences
Year
2013
Authors
D. Ouellet, K. Grossmann, Giselle Limentani, N. Nebot, Kevin Lan, L. Knowles, M. Gordon, Sunil Sharma, J. Infante, P. LoRusso, G. Pande, Elizabeth C. Krachey, S. Blackman, S. Carson
48 citations